Related Experiment Video

Updated: Aug 13, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Correction: Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia

Guillermo Quintero¹, Sandra Aruachan², Jair Figueroa Emiliani³

¹Fundación Santa Fe de Bogotá, Bogotá, Colombia.

Frontiers in Oncology

|August 12, 2026

Abstract:

[This corrects the article DOI: 10.3389/fonc.2026.1831845.].

Keywords:

effectiveness multiple myeloma real-world evidence safety treatment patterns

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Therapeutic challenges in the management of chronic myeloid leukemia during pregnancy: A report of two cases.

Case reports in women's health·2026

Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia (freedomm): a multicenter observational study.

Frontiers in oncology·2026

Awareness, attitudes, and barriers toward Transthyretin Amyloid Cardiomyopathy in Latin America: A questionnaire-based cross-sectional study.

PloS one·2026

Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort.

Leukemia research·2026

Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial.

Lancet (London, England)·2026

Economic benefit of expanding mammography screening for breast cancer in Colombia: A cost modelling analysis.

Public health in practice (Oxford, England)·2026

See all related articles